JG
BPMC

Jain Global’s Blueprint Medicines BPMC Stock Holding History

Jain Global’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-64,130
Closed -$8.22M – 1060
2025
Q2 		$8.22M Buy
64,130
+36,509
+132% +$3.79M 0.06% 253
2025
Q1 		$2.44M Buy
27,621
+12,647
+84% +$1.23M 0.03% 327
2024
Q4 		$1.31M Buy
+14,974
New +$1.37M 0.04% 285

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jain Global's BPMC Position: Q3 2025 in Review

Jain Global sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 64,130 shares — an estimated $8.22M sold.

Jain Global first reported a position in BPMC in Q4 2024 and held it in 3 quarters. The position peaked at $8.22M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Jain Global reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Jain Global sold 64,130 Blueprint Medicines shares in Q3 2025, an estimated $8.22M.
  • Jain Global first reported a position in Blueprint Medicines in Q4 2024 and held it in 3 quarters.
  • Jain Global's Blueprint Medicines position peaked at $8.22M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Jain Global's 13F filing for Q3 2025, filed 14 Nov 2025.